Latest Australian Market News

RLF AgTech Ltd has successfully raised approximately $2.42 million through an Entitlement Issue and Shortfall Placement, reflecting strong shareholder confidence in its turnaround strategy and growth prospects in Australia and Asia.

PARKD has inked a pivotal five-year exclusive licensing agreement with Fielders, a BlueScope Steel division, to commercialise its innovative MDSB® and MDSS® products in Australia and explore international expansion.

Hotel Property Investments (HPI) reported a resilient H1 FY25 with a $1.26 billion portfolio and upgraded its distribution guidance to 19.7 cents per security, despite significant governance changes amid a takeover bid.

ImpediMed Limited has locked in a US$15 million growth capital facility with SWK Funding LLC, providing crucial financial flexibility to advance its SOZO Digital Health Platform and commercial ambitions.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for three Australian iShares ETFs, outlining key dates and reinvestment options for investors.

Centuria Office REIT has released its HY25 Property Compendium, revealing a robust $1.885 billion portfolio diversified across Australia with strong occupancy and sustainable credentials.

Yowie Group’s Q2 FY25 results reveal a mixed performance with a 33% revenue drop in North America offset by growth in Australia and ongoing cost optimisation efforts.

Stakk Limited has marked a pivotal quarter with the acquisition of US fintech R-DBX, generating $1.6 million in revenue, and secured a $1 million working capital facility to fuel its Embedded Finance growth strategy.

Wellnex Life Limited reported a 36% rise in Q2 FY25 cash receipts and record monthly sales, while advancing its dual listing on the London Stock Exchange and expanding into the UK market.

Clarity Pharmaceuticals reports robust progress in its SECURE trial and secures FDA Fast Track Designation for its diagnostic agent 64Cu-SAR-bisPSMA, underpinning its growth and innovation in prostate cancer treatment.

Golden Horse Minerals has successfully listed on the ASX, raising A$18 million to fund exploration across a consolidated 130km strike in Western Australia's Southern Cross Greenstone Belt. The company is gearing up for a major drilling campaign at the historic Hopes Hill gold mine.